Cargando…

Left Ventricular Hypertrophy and Hypertrophic Cardiomyopathy in Adult Solid Organ Transplant Recipients

BACKGROUND. Hypertrophic cardiomyopathy (HCM) in pediatric solid organ transplant recipients has been reported in association with use of calcineurin inhibitors. However, data on the incidence and prevalence of HCM in adult posttransplant patients are limited. We sought to describe the clinical char...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reza, Nosheen, De Feria, Alejandro, Wang, Teresa, Chowns, Jessica L., Hoffman-Andrews, Lily, Kim, Jessica, Hornsby, Nicole, Marzolf, Amy, Atluri, Pavan, Herrmann, Howard C., Owens, Anjali Tiku
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Clinical Method
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670585/ https://www.ncbi.nlm.nih.gov/pubmed/34912951 http://dx.doi.org/10.1097/TXD.0000000000001279

Ejemplares similares

Cardiovascular Characteristics of Patients with Genetic Variation in Desmoplakin (DSP)
por: Reza, Nosheen, et al.
Publicado: (2022)

Contemporary Therapies and Future Directions in the Management of Hypertrophic Cardiomyopathy
por: Packard, Elizabeth, et al.
Publicado: (2022)

Antepartum Diagnosis and Management of Lamin A/C Disease
por: Reza, Nosheen, et al.
Publicado: (2019)

Cardiac Amyloidosis Masked as Hypertrophic Cardiomyopathy: A Case Report
por: Wang, Jing, et al.
Publicado: (2016)

Data-driven modelling of mutational hotspots and in silico predictors in hypertrophic cardiomyopathy
por: Waring, Adam, et al.
Publicado: (2021)

Hypertrophic cardiomyopathy with little hypertrophy and severe arrhythmia
por: Ripoll-Vera, Tomas, et al.
Publicado: (2018)

Familial Hypertrophic Cardiomyopathy: Diagnosis and Management
por: Litt, Michael J, et al.
Publicado: (2023)

Endogenous T1ρ cardiovascular magnetic resonance in hypertrophic cardiomyopathy
por: Thompson, Elizabeth W., et al.
Publicado: (2021)

Subaortic and midventricular obstructive hypertrophic cardiomyopathy with extreme segmental hypertrophy
por: Efthimiadis, Georgios K, et al.
Publicado: (2007)

Extreme septal hypertrophy in an adolescent with congenital familial hypertrophic cardiomyopathy
por: Park, Byoung-Won, et al.
Publicado: (2015)

Atrial Fibrillation in Hypertrophic Cardiomyopathy: Is the Extent of Septal Hypertrophy Important?
por: Park, Kyoung-min, et al.
Publicado: (2016)

Targeted sequence capture and GS-FLX Titanium sequencing of 23 hypertrophic and dilated cardiomyopathy genes: implementation into diagnostics
por: Mook, Olaf R F, et al.
Publicado: (2013)

The effect of inhibition of the Na(+)/H(+) exchanger on the development of hypertrophy in hypertrophic cardiomyopathy
por: Brouwer, Wessel P, et al.
Publicado: (2011)

Effect of hypertrophy on left ventricular diastolic function in patients with hypertrophic cardiomyopathy
por: CIAMPI, QUIRINO, et al.
Publicado: (2006)

Cardiotrophin-1 plasma levels are associated with the severity of hypertrophy in hypertrophic cardiomyopathy
por: Monserrat, Lorenzo, et al.
Publicado: (2011)

Electro‐ and echocardiographic features of left ventricle hypertrophy in patients with hypertrophic cardiomyopathy
por: Bula, Karolina, et al.
Publicado: (2022)

Sarcomere mutation negative hypertrophic cardiomyopathy is associated with ageing and obesity
por: de Feria, Alejandro E, et al.
Publicado: (2021)

Reversible Apical Hypertrophy in a Young Competitive Athlete with Familiar Hypertrophic Cardiomyopathy
por: Di Gioia, Giuseppe, et al.
Publicado: (2023)

Left ventricular anatomy in obstructive hypertrophic cardiomyopathy: beyond basal septal hypertrophy
por: Hermida, Uxio, et al.
Publicado: (2022)

Living with hypertrophic cardiomyopathy and an implantable defibrillator
por: Magnusson, Peter, et al.
Publicado: (2017)

An Unusual Presentation of Apical Hypertrophic Cardiomyopathy in an Orthotopic Heart Transplant Recipient
por: Molina-Lopez, Victor H, et al.
Publicado: (2023)

Applying Shared Decision Making to Sports Participation for a Patient With Hypertrophic Cardiomyopathy
por: de Feria, Alejandro E., et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy: Prevalence, Hypertrophy Patterns, and Their Clinical and ECG Findings in a Hospital at Qatar
por: Helmy, Sherif M., et al.
Publicado: (2011)

Comparison of the Clinical Features of Apical Hypertrophic Cardiomyopathy Versus Asymmetric Septal Hypertrophy in Korea
por: Yang, Hyun Suk, et al.
Publicado: (2005)

Increased Postnatal Cardiac Hyperplasia Precedes Cardiomyocyte Hypertrophy in a Model of Hypertrophic Cardiomyopathy
por: Farrell, Emily T., et al.
Publicado: (2017)

From 100 to 0: Endocardial Radiofrequency Ablation of Septal Hypertrophy for Management of Hypertrophic Cardiomyopathy
por: Peigh, Graham, et al.
Publicado: (2020)

Regression of Left Ventricular Hypertrophy in a Case of Sarcomeric Hypertrophic Cardiomyopathy: An Unexpected Outcome
por: Cabrera Borrego, Eva, et al.
Publicado: (2020)

Differential Expression of microRNAs in Hypertrophied Myocardium and Their Relationship to Late Gadolinium Enhancement, Left Ventricular Hypertrophy and Remodeling in Hypertrophic Cardiomyopathy
por: Zhang, Chen, et al.
Publicado: (2022)

Diagnosis of apical hypertrophic cardiomyopathy: T-wave inversion and relative but not absolute apical left ventricular hypertrophy()
por: Flett, Andrew S., et al.
Publicado: (2015)

A novel approach in the use of radiofrequency catheter ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy
por: Shelke, Abhijeet B., et al.
Publicado: (2016)

The clinical features, outcomes and genetic characteristics of hypertrophic cardiomyopathy patients with severe right ventricular hypertrophy
por: Guo, Xiying, et al.
Publicado: (2017)

MicroRNA-221 is a potential biomarker of myocardial hypertrophy and fibrosis in hypertrophic obstructive cardiomyopathy
por: Huang, Derong, et al.
Publicado: (2020)

Hypertrophic cardiomyopathy
por: Antunes, Murillo de Oliveira, et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy
por: Butt, Asra K., et al.
Publicado: (2023)

T1 Mapping and Extracellular Volume in Cardiomyopathy Showing Left Ventricular Hypertrophy: Differentiation Between Hypertrophic Cardiomyopathy and Hypertensive Heart Disease
por: Liang, Lu, et al.
Publicado: (2022)

Relationship between myocardial scar and hypertrophy by LGE CMR in hypertrophic cardiomyopathy patients with and without clinical events
por: Kino, Aya, et al.
Publicado: (2012)

Mid-Septal Hypertrophy and Apical Ballooning; Potential Mechanism of Ventricular Tachycardia Storm in Patients with Hypertrophic Cardiomyopathy
por: Hwang, Eui-Seock, et al.
Publicado: (2012)

Elevated high-sensitivity cardiac troponin is associated with hypertrophy and fibrosis assessed with CMR in patients with hypertrophic cardiomyopathy
por: Gommans, Frank, et al.
Publicado: (2013)

An Atypical Case of Apical Hypertrophic Cardiomyopathy: Absence of Giant T Waves in spite of Extreme Apical Wall Hypertrophy
por: Sanidas, Elias, et al.
Publicado: (2015)

Myocardial triglyceride content in patients with left ventricular hypertrophy: comparison between hypertensive heart and hypertrophic cardiomyopathy
por: Sai, Eiryu, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_eml1svct5r22k8ed5geda7sfrc